| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
13,332.9530 | 13,332.9530 | 8,426.8350 | 2,645.0720 | 3,455.8130 |
| Cost of Revenue
|
-11,194.7540 | -11,194.7540 | -6,920.1300 | -2,134.7250 | -2,767.8180 |
|
Gross Profit
|
2,138.1990 | 2,138.1990 | 1,506.7050 | 510.3470 | 687.9950 |
| Selling, General and Administrative Expenses
|
-18,347.0460 | -18,347.0460 | -6,065.5900 | -2,828.1470 | -3,293.7580 |
|
Research and Development Expenses
|
-1,556.0430 | -1,556.0430 | -157.3050 | -19.1540 | -29.9360 |
| Depreciation, Amortization and Depletion
|
-376.8270 | -376.8270 | 0 | -- | -- |
|
Operating Income/Expenses
|
-20,279.9160 | -20,279.9160 | -6,222.8950 | -2,847.3010 | -3,323.6940 |
|
Total Operating Profit/Loss
|
-18,141.7170 | -18,141.7170 | -4,716.1900 | -2,336.9540 | -2,635.6990 |
| Total Net Finance Income/Expense
|
-529.9660 | -529.9660 | -318.4060 | 33.6440 | -4.1340 |
| Irregular Income/Expenses
|
-2,799.0280 | -2,799.0280 | 0 | -- | -- |
|
Non-Operating Income/Expenses, Total
|
-3,328.9940 | -3,328.9940 | -318.4060 | 33.6440 | -4.1340 |
|
Pretax Income
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
|
Net Income from Continuing Operations
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
|
Net Income after Non-Controlling/Minority Interests
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
|
Net Income Available to Common Stockholders
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
|
Diluted Net Income Available to Common Stockholders
|
-21,470.7110 | -21,470.7110 | -5,034.5960 | -2,303.3100 | -2,639.8330 |
| Basic EPS
|
-0.55 | -0.55 | -0.15 | -0.07 | -0.08 |
| Diluted EPS
|
-0.55 | -0.55 | -0.15 | -0.07 | -0.08 |
|
Basic Weighted Average Shares Outstanding
|
39,294.0320 | 39,294.0320 | 33,589.8180 | 33,213.3060 | 32,025.6200 |
|
Diluted Weighted Average Shares Outstanding
|
39,294.0320 | 39,294.0320 | 33,589.8180 | 33,213.3060 | 32,025.6200 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-20,940.7450 | -20,940.7450 | -4,716.1900 | -2,336.9540 | -2,635.6990 |
|
EBITDA
|
-20,290.9340 | -20,290.9340 | -4,635.6200 | -2,336.9540 | -2,635.6990 |
|
Normalized EBITDA
|
-12,801.4490 | -12,801.4490 | -2,614.7030 | -1,904.5870 | -1,106.4080 |
|
Normalized Income
|
-12,442.2130 | -12,442.2130 | -2,933.1080 | -1,870.9430 | -1,110.5420 |
|
Total Unusual Items
|
9,028.4980 | 9,028.4980 | 2,101.4880 | 432.3670 | 1,529.2910 |
|
Total Unusual Items Excluding Goodwill
|
9,028.4980 | 9,028.4980 | 2,101.4880 | 432.3670 | 1,529.2910 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
6/30/2023 - 5/20/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade